Drugs giant Shire Pharmaeuticals helped the FTSE 100 index to cross the psychological 4,600 barrier again this afternoon, after announcing it has distribution approval in the US.
The FTSE 100 index eventually closed up 46.7 points or just over 1% to 4,630 thanks largely to Shire Pharmaceutical positive news about the approval of its treatment for kidney failure patients. Shire eventually closed the day up just 4.25p or 0.81% to 526p, having earlier in the day gained over 2% in value. After BP’s profit surge yesterday, Shell Transport & Trading is now being closely watched by analysts as the Royal Dutch/Shell Group – a 40% share of which Shell Transport holds - reports its earnings tomorrow and could therefore boost the STT price. Its share price gained 11.75p ...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
